APO Research, Inc.

APO RESEARCH · REPORT

Advance Directives Software

Selected research

Market Analysis & Forecast

Global Advance Directives Software Market Analysis and Forecast 2026-2032

Market perspective

The global Advance Directives Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Advance Directives Software include Island Health, Honor My Decisions, WiserCare Inc., ADvault, Inc., VyncaCare, Iris Healthcare, Bronson Health Care Group, Inc., Koda Health and New Century Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Advance Directives Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Advance Directives Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Advance Directives Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Advance Directives Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Advance Directives Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Advance Directives Software revenue, projected growth trends, production technology, application and end-user industry.

Advance Directives Software Segment by Company

Island Health

Honor My Decisions

WiserCare Inc.

ADvault, Inc.

VyncaCare

Iris Healthcare

Bronson Health Care Group, Inc.

Koda Health

New Century Health

Thanacare

ThroughCare, Inc.

Vital Decisions

Affirm Health Inc.

MIDEO

Sharp HealthCare

ACP Decisions

Advance Directives Software Segment by Type

Document Preparation Software

Electronic Health Record (EHR) Integration

Online Platforms and Portals

Comprehensive Healthcare Planning Software

Advance Directives Software Segment by Application

Healthcare

Other

Advance Directives Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advance Directives Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advance Directives Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advance Directives Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Advance Directives Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Advance Directives Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advance Directives Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Advance Directives Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Document Preparation Software Major Player Table 3. Electronic Health Record (EHR) Integration Major Player Table 4. Online Platforms and Portals Major Player Table 5. Comprehensive Healthcare Planning Software Major Player Table 6. Global Advance Directives Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Healthcare Major Player Table 8. Other Major Player Table 9. Advance Directives Software Industry Trends Table 10. Advance Directives Software Industry Drivers Table 11. Advance Directives Software Industry Opportunities and Challenges Table 12. Advance Directives Software Industry Restraints Table 13. Global Advance Directives Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Advance Directives Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Advance Directives Software Market Share by Region (2021-2026) Table 16. Global Advance Directives Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Advance Directives Software Market Share by Region (2027-2032) Table 18. Global Advance Directives Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Advance Directives Software Revenue Market Share by Players (2021-2026) Table 20. Global Advance Directives Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Advance Directives Software Key Players Headquarters & Area Served Table 22. Global Advance Directives Software Players, Product Type & Application Table 23. Global Advance Directives Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Advance Directives Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Advance Directives Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Advance Directives Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Advance Directives Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Advance Directives Software Revenue Market Share by Type (2021-2026) Table 30. Global Advance Directives Software Revenue Market Share by Type (2027-2032) Table 31. Global Advance Directives Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Advance Directives Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Advance Directives Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Advance Directives Software Revenue Market Share by Application (2021-2026) Table 35. Global Advance Directives Software Revenue Market Share by Application (2027-2032) Table 36. Island Health Company Information Table 37. Island Health Business Overview Table 38. Island Health Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Island Health Advance Directives Software Product Portfolio Table 40. Island Health Recent Development Table 41. Honor My Decisions Company Information Table 42. Honor My Decisions Business Overview Table 43. Honor My Decisions Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Honor My Decisions Advance Directives Software Product Portfolio Table 45. Honor My Decisions Recent Development Table 46. WiserCare Inc. Company Information Table 47. WiserCare Inc. Business Overview Table 48. WiserCare Inc. Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. WiserCare Inc. Advance Directives Software Product Portfolio Table 50. WiserCare Inc. Recent Development Table 51. ADvault, Inc. Company Information Table 52. ADvault, Inc. Business Overview Table 53. ADvault, Inc. Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. ADvault, Inc. Advance Directives Software Product Portfolio Table 55. ADvault, Inc. Recent Development Table 56. VyncaCare Company Information Table 57. VyncaCare Business Overview Table 58. VyncaCare Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. VyncaCare Advance Directives Software Product Portfolio Table 60. VyncaCare Recent Development Table 61. Iris Healthcare Company Information Table 62. Iris Healthcare Business Overview Table 63. Iris Healthcare Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Iris Healthcare Advance Directives Software Product Portfolio Table 65. Iris Healthcare Recent Development Table 66. Bronson Health Care Group, Inc. Company Information Table 67. Bronson Health Care Group, Inc. Business Overview Table 68. Bronson Health Care Group, Inc. Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Bronson Health Care Group, Inc. Advance Directives Software Product Portfolio Table 70. Bronson Health Care Group, Inc. Recent Development Table 71. Koda Health Company Information Table 72. Koda Health Business Overview Table 73. Koda Health Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Koda Health Advance Directives Software Product Portfolio Table 75. Koda Health Recent Development Table 76. New Century Health Company Information Table 77. New Century Health Business Overview Table 78. New Century Health Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. New Century Health Advance Directives Software Product Portfolio Table 80. New Century Health Recent Development Table 81. Thanacare Company Information Table 82. Thanacare Business Overview Table 83. Thanacare Advance Directives Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Thanacare Advance Directives Software Product Portfolio Table 85. Thanacare Recent Development Table 86. ThroughCare, Inc. Company Information Table 87. ThroughCare, Inc. Business Overview Table 88. ThroughCare, Inc. Advance Directives Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. ThroughCare, Inc. Advance Directives Software Product Portfolio Table 90. ThroughCare, Inc. Recent Development Table 91. Vital Decisions Company Information Table 92. Vital Decisions Business Overview Table 93. Vital Decisions Advance Directives Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Vital Decisions Advance Directives Software Product Portfolio Table 95. Vital Decisions Recent Development Table 96. Affirm Health Inc. Company Information Table 97. Affirm Health Inc. Business Overview Table 98. Affirm Health Inc. Advance Directives Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Affirm Health Inc. Advance Directives Software Product Portfolio Table 100. Affirm Health Inc. Recent Development Table 101. MIDEO Company Information Table 102. MIDEO Business Overview Table 103. MIDEO Advance Directives Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. MIDEO Advance Directives Software Product Portfolio Table 105. MIDEO Recent Development Table 106. Sharp HealthCare Company Information Table 107. Sharp HealthCare Business Overview Table 108. Sharp HealthCare Advance Directives Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Sharp HealthCare Advance Directives Software Product Portfolio Table 110. Sharp HealthCare Recent Development Table 111. ACP Decisions Company Information Table 112. ACP Decisions Business Overview Table 113. ACP Decisions Advance Directives Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. ACP Decisions Advance Directives Software Product Portfolio Table 115. ACP Decisions Recent Development Table 116. North America Advance Directives Software Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Advance Directives Software Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Advance Directives Software Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Advance Directives Software Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Advance Directives Software Revenue by Country (2021-2026) & (US$ Million) Table 122. North America Advance Directives Software Revenue by Country (US$ Million) & (2027-2032) Table 123. Europe Advance Directives Software Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe Advance Directives Software Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe Advance Directives Software Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Advance Directives Software Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Advance Directives Software Revenue by Country (2021-2026) & (US$ Million) Table 129. Europe Advance Directives Software Revenue by Country (US$ Million) & (2027-2032) Table 130. China Advance Directives Software Revenue by Type (2021-2026) & (US$ Million) Table 131. China Advance Directives Software Revenue by Type (2027-2032) & (US$ Million) Table 132. China Advance Directives Software Revenue by Application (2021-2026) & (US$ Million) Table 133. China Advance Directives Software Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Advance Directives Software Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Advance Directives Software Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Advance Directives Software Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia Advance Directives Software Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Advance Directives Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Advance Directives Software Revenue by Region (US$ Million) & (2021-2026) Table 140. Asia Advance Directives Software Revenue by Region (US$ Million) & (2027-2032) Table 141. SAMEA Advance Directives Software Revenue by Type (2021-2026) & (US$ Million) Table 142. SAMEA Advance Directives Software Revenue by Type (2027-2032) & (US$ Million) Table 143. SAMEA Advance Directives Software Revenue by Application (2021-2026) & (US$ Million) Table 144. SAMEA Advance Directives Software Revenue by Application (2027-2032) & (US$ Million) Table 145. SAMEA Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. SAMEA Advance Directives Software Revenue by Country (2021-2026) & (US$ Million) Table 147. SAMEA Advance Directives Software Revenue by Country (US$ Million) & (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Advance Directives Software Image Figure 2. Global Advance Directives Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advance Directives Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Document Preparation Software Image Figure 5. Electronic Health Record (EHR) Integration Image Figure 6. Online Platforms and Portals Image Figure 7. Comprehensive Healthcare Planning Software Image Figure 8. Global Advance Directives Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Advance Directives Software Market Size Share 2021 VS 2025 VS 2032 Figure 10. Healthcare Image Figure 11. Other Image Figure 12. Global Advance Directives Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Advance Directives Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Advance Directives Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Advance Directives Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Advance Directives Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Advance Directives Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Advance Directives Software Revenue Market Share by Type (2021-2032) Figure 20. Global Advance Directives Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Advance Directives Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Advance Directives Software Revenue Market Share by Application (2021-2032) Figure 23. North America Advance Directives Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Advance Directives Software Revenue Share by Type (2021-2032) Figure 25. North America Advance Directives Software Revenue Share by Application (2021-2032) Figure 26. North America Advance Directives Software Revenue Share by Country (2021-2032) Figure 27. United States Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Advance Directives Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Advance Directives Software Revenue Share by Type (2021-2032) Figure 32. Europe Advance Directives Software Revenue Share by Application (2021-2032) Figure 33. Europe Advance Directives Software Revenue Share by Country (2021-2032) Figure 34. Germany Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Advance Directives Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Advance Directives Software Revenue Share by Type (2021-2032) Figure 44. China Advance Directives Software Revenue Share by Application (2021-2032) Figure 45. Asia Advance Directives Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Advance Directives Software Revenue Share by Type (2021-2032) Figure 47. Asia Advance Directives Software Revenue Share by Application (2021-2032) Figure 48. Asia Advance Directives Software Revenue Share by Region (2021-2032) Figure 49. Japan Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Advance Directives Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Advance Directives Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Advance Directives Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Advance Directives Software Revenue Share by Country (2021-2032) Figure 59. Brazil Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Advance Directives Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Document Preparation Software
  • Electronic Health Record (EHR) Integration
  • Online Platforms and Portals
  • Comprehensive Healthcare Planning Software
Applications
  • Healthcare
  • Other
Companies covered
  • Island Health
  • Honor My Decisions
  • WiserCare Inc.
  • ADvault, Inc.
  • VyncaCare
  • Iris Healthcare
  • Bronson Health Care Group, Inc.
  • Koda Health
  • New Century Health
  • Thanacare
  • ThroughCare, Inc.
  • Vital Decisions
  • Affirm Health Inc.
  • MIDEO
  • Sharp HealthCare
  • ACP Decisions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Advance Directives Software Market by Type
  3. 1.2.1 Global Advance Directives Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Document Preparation Software
  5. 1.2.3 Electronic Health Record (EHR) Integration
  6. 1.2.4 Online Platforms and Portals
  7. 1.2.5 Comprehensive Healthcare Planning Software
  8. 1.3 Advance Directives Software Market by Application
  9. 1.3.1 Global Advance Directives Software Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Healthcare
  11. 1.3.3 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Advance Directives Software Market Dynamics
  1. 2.1 Advance Directives Software Industry Trends
  2. 2.2 Advance Directives Software Industry Drivers
  3. 2.3 Advance Directives Software Industry Opportunities and Challenges
  4. 2.4 Advance Directives Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Advance Directives Software Market Perspective (2021-2032)
  2. 3.2 Global Advance Directives Software Growth Trends by Region
  3. 3.2.1 Global Advance Directives Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Advance Directives Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Advance Directives Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Advance Directives Software Revenue by Players
  2. 4.1.1 Global Advance Directives Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Advance Directives Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Advance Directives Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Advance Directives Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Advance Directives Software Key Players Headquarters & Area Served
  7. 4.4 Global Advance Directives Software Players, Product Type & Application
  8. 4.5 Global Advance Directives Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Advance Directives Software Market CR5 and HHI
  11. 4.6.3 2025 Advance Directives Software Tier 1, Tier 2, and Tier 3
5 Advance Directives Software Market Size by Type
  1. 5.1 Global Advance Directives Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Advance Directives Software Revenue by Type (2021-2032)
  3. 5.3 Global Advance Directives Software Revenue Market Share by Type (2021-2032)
6 Advance Directives Software Market Size by Application
  1. 6.1 Global Advance Directives Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Advance Directives Software Revenue by Application (2021-2032)
  3. 6.3 Global Advance Directives Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Island Health
  2. 7.1.1 Island Health Company Information
  3. 7.1.2 Island Health Business Overview
  4. 7.1.3 Island Health Advance Directives Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Island Health Advance Directives Software Product Portfolio
  6. 7.1.5 Island Health Recent Developments
  7. 7.2 Honor My Decisions
  8. 7.2.1 Honor My Decisions Company Information
  9. 7.2.2 Honor My Decisions Business Overview
  10. 7.2.3 Honor My Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Honor My Decisions Advance Directives Software Product Portfolio
  12. 7.2.5 Honor My Decisions Recent Developments
  13. 7.3 WiserCare Inc.
  14. 7.3.1 WiserCare Inc. Company Information
  15. 7.3.2 WiserCare Inc. Business Overview
  16. 7.3.3 WiserCare Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 WiserCare Inc. Advance Directives Software Product Portfolio
  18. 7.3.5 WiserCare Inc. Recent Developments
  19. 7.4 ADvault, Inc.
  20. 7.4.1 ADvault, Inc. Company Information
  21. 7.4.2 ADvault, Inc. Business Overview
  22. 7.4.3 ADvault, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ADvault, Inc. Advance Directives Software Product Portfolio
  24. 7.4.5 ADvault, Inc. Recent Developments
  25. 7.5 VyncaCare
  26. 7.5.1 VyncaCare Company Information
  27. 7.5.2 VyncaCare Business Overview
  28. 7.5.3 VyncaCare Advance Directives Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 VyncaCare Advance Directives Software Product Portfolio
  30. 7.5.5 VyncaCare Recent Developments
  31. 7.6 Iris Healthcare
  32. 7.6.1 Iris Healthcare Company Information
  33. 7.6.2 Iris Healthcare Business Overview
  34. 7.6.3 Iris Healthcare Advance Directives Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Iris Healthcare Advance Directives Software Product Portfolio
  36. 7.6.5 Iris Healthcare Recent Developments
  37. 7.7 Bronson Health Care Group, Inc.
  38. 7.7.1 Bronson Health Care Group, Inc. Company Information
  39. 7.7.2 Bronson Health Care Group, Inc. Business Overview
  40. 7.7.3 Bronson Health Care Group, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bronson Health Care Group, Inc. Advance Directives Software Product Portfolio
  42. 7.7.5 Bronson Health Care Group, Inc. Recent Developments
  43. 7.8 Koda Health
  44. 7.8.1 Koda Health Company Information
  45. 7.8.2 Koda Health Business Overview
  46. 7.8.3 Koda Health Advance Directives Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Koda Health Advance Directives Software Product Portfolio
  48. 7.8.5 Koda Health Recent Developments
  49. 7.9 New Century Health
  50. 7.9.1 New Century Health Company Information
  51. 7.9.2 New Century Health Business Overview
  52. 7.9.3 New Century Health Advance Directives Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 New Century Health Advance Directives Software Product Portfolio
  54. 7.9.5 New Century Health Recent Developments
  55. 7.10 Thanacare
  56. 7.10.1 Thanacare Company Information
  57. 7.10.2 Thanacare Business Overview
  58. 7.10.3 Thanacare Advance Directives Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Thanacare Advance Directives Software Product Portfolio
  60. 7.10.5 Thanacare Recent Developments
  61. 7.11 ThroughCare, Inc.
  62. 7.11.1 ThroughCare, Inc. Company Information
  63. 7.11.2 ThroughCare, Inc. Business Overview
  64. 7.11.3 ThroughCare, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ThroughCare, Inc. Advance Directives Software Product Portfolio
  66. 7.11.5 ThroughCare, Inc. Recent Developments
  67. 7.12 Vital Decisions
  68. 7.12.1 Vital Decisions Company Information
  69. 7.12.2 Vital Decisions Business Overview
  70. 7.12.3 Vital Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Vital Decisions Advance Directives Software Product Portfolio
  72. 7.12.5 Vital Decisions Recent Developments
  73. 7.13 Affirm Health Inc.
  74. 7.13.1 Affirm Health Inc. Company Information
  75. 7.13.2 Affirm Health Inc. Business Overview
  76. 7.13.3 Affirm Health Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Affirm Health Inc. Advance Directives Software Product Portfolio
  78. 7.13.5 Affirm Health Inc. Recent Developments
  79. 7.14 MIDEO
  80. 7.14.1 MIDEO Company Information
  81. 7.14.2 MIDEO Business Overview
  82. 7.14.3 MIDEO Advance Directives Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 MIDEO Advance Directives Software Product Portfolio
  84. 7.14.5 MIDEO Recent Developments
  85. 7.15 Sharp HealthCare
  86. 7.15.1 Sharp HealthCare Company Information
  87. 7.15.2 Sharp HealthCare Business Overview
  88. 7.15.3 Sharp HealthCare Advance Directives Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Sharp HealthCare Advance Directives Software Product Portfolio
  90. 7.15.5 Sharp HealthCare Recent Developments
  91. 7.16 ACP Decisions
  92. 7.16.1 ACP Decisions Company Information
  93. 7.16.2 ACP Decisions Business Overview
  94. 7.16.3 ACP Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 ACP Decisions Advance Directives Software Product Portfolio
  96. 7.16.5 ACP Decisions Recent Developments
8 North America
  1. 8.1 North America Advance Directives Software Revenue (2021-2032)
  2. 8.2 North America Advance Directives Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Advance Directives Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Advance Directives Software Revenue by Type (2027-2032)
  5. 8.3 North America Advance Directives Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Advance Directives Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Advance Directives Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Advance Directives Software Revenue by Application (2027-2032)
  9. 8.5 North America Advance Directives Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Advance Directives Software Revenue by Country
  11. 8.6.1 North America Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Advance Directives Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Advance Directives Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Advance Directives Software Revenue (2021-2032)
  2. 9.2 Europe Advance Directives Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Advance Directives Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Advance Directives Software Revenue by Type (2027-2032)
  5. 9.3 Europe Advance Directives Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Advance Directives Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Advance Directives Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Advance Directives Software Revenue by Application (2027-2032)
  9. 9.5 Europe Advance Directives Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Advance Directives Software Revenue by Country
  11. 9.6.1 Europe Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Advance Directives Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Advance Directives Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Advance Directives Software Revenue (2021-2032)
  2. 10.2 China Advance Directives Software Revenue by Type (2021-2032)
  3. 10.2.1 China Advance Directives Software Revenue by Type (2021-2026)
  4. 10.2.2 China Advance Directives Software Revenue by Type (2027-2032)
  5. 10.3 China Advance Directives Software Revenue Share by Type (2021-2032)
  6. 10.4 China Advance Directives Software Revenue by Application (2021-2032)
  7. 10.4.1 China Advance Directives Software Revenue by Application (2021-2026)
  8. 10.4.2 China Advance Directives Software Revenue by Application (2027-2032)
  9. 10.5 China Advance Directives Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Advance Directives Software Revenue (2021-2032)
  2. 11.2 Asia Advance Directives Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Advance Directives Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Advance Directives Software Revenue by Type (2027-2032)
  5. 11.3 Asia Advance Directives Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Advance Directives Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Advance Directives Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Advance Directives Software Revenue by Application (2027-2032)
  9. 11.5 Asia Advance Directives Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Advance Directives Software Revenue by Country
  11. 11.6.1 Asia Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Advance Directives Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Advance Directives Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Advance Directives Software Revenue (2021-2032)
  2. 12.2 SAMEA Advance Directives Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Advance Directives Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Advance Directives Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Advance Directives Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Advance Directives Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Advance Directives Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Advance Directives Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Advance Directives Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Advance Directives Software Revenue by Country
  11. 12.6.1 SAMEA Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Advance Directives Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Advance Directives Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.